CN Patent

CN102895178B — 一种盐酸莫西沙星浓溶液型注射剂及其制备方法

Assigned to Chengdu Guowei Biopharmaceutical Co.,Ltd. · Expires 2015-04-08 · 11y expired

What this patent protects

本发明涉及一种含有不含硫氨基酸或其药学上可接受的盐的盐酸莫西沙星浓溶液型注射剂及其制备方法。该种盐酸莫西沙星浓溶液型注射剂中所含的增溶剂用量更小，安全性更好；同时对于提高盐酸莫西沙星浓溶液的溶解性、稳定性，效果更加显著；而且制备出的注射液质量更加稳定；且制备工艺流程简单，操作简便。

USPTO Abstract

本发明涉及一种含有不含硫氨基酸或其药学上可接受的盐的盐酸莫西沙星浓溶液型注射剂及其制备方法。该种盐酸莫西沙星浓溶液型注射剂中所含的增溶剂用量更小，安全性更好；同时对于提高盐酸莫西沙星浓溶液的溶解性、稳定性，效果更加显著；而且制备出的注射液质量更加稳定；且制备工艺流程简单，操作简便。

Drugs covered by this patent

Patent Metadata

Patent number
CN102895178B
Jurisdiction
CN
Classification
—
Expires
2015-04-08
Drug substance claim
No
Drug product claim
No
Assignee
Chengdu Guowei Biopharmaceutical Co.,Ltd.
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.